prod:prod_dcx-login
Cepheid
Editorial Team
Follow
Share
2m Read
11 de septiembre de 2024
COMMUNITY AND GLOBAL HEALTH
Impact Story
HCV Treatment Drastically Improved by Faster Prison Testing in the U.K.
Tratar a los presos que dan positivo para el VHC constituye una parte crucial de la iniciativa global para eliminar la enfermedad, ya que ayuda a reducir las tasas de infección dentro y fuera de la cárcel.
The current standard pathway for testing, which takes two to three weeks to get the result, is too slow, and many inmates are released from prison before starting treatment.
Providing access to a simplified test-and-treat pathway through point-of-care HCV RNA testing with Xpert® HCV VL Fingerstick provides results in less than an hour.
"The sooner you can get somebody diagnosed and onto treatment, the better it is for that individual and for the community inside and outside the prison.”
Ashley Brown, hepatóloga especialista en Imperial College Healthcare NHS Trusty HMP Wormwood Scrubs Prison
According to Ashley Brown, Consultant Hepatologist at Imperial College Healthcare NHS Trust and HMP Wormwood Scrubs Prison, implementing the GeneXpert® system as part of the HCV testing pathway enabled the institution to know the status of new inmates in one day instead of two to three weeks.
“It meant 60% more prisoners were able to achieve that treatment period,” Brown notes. “When we follow them up, the vast majority are achieving clearance of the virus, and it is modifying their behaviour, making them less likely to take additional risks."
Using the GeneXpert system at the Wormwood Scrubs prison allowed inmates to find out if they had an HCV active infection on the same day as they were tested. Los reclusos que dan positivo en las pruebas comienzan el tratamiento en el plazo de cuatro días desde el diagnóstico, lo que mejora considerablemente el proceso asistencial y se traduce en un aumento significativo del número de reclusos que inician el tratamiento.
Watch to learn how point-of-care testing simplifies HCV's diagnostics pathway in prisons.
Cepheid’s testing solution provides medically actionable information to healthcare professionals, enabling same-day testing and treatments for infectious disease management.
Learn more about the GeneXpert® system.
CE-IVD. Producto sanitario para diagnóstico in vitro. Es posible que no esté disponible en todos los países. No disponible en Estados Unidos.
Bibliografía:
Z.Mohamed, et al. Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in England. Int J Drug Policy. 2020 Jan;75:102608. https://pubmed.ncbi.nlm.nih.gov/31759307/
Point-of-Care Testing Simplifies the Diagnostics Pathway for Hepatitis C in Prisons. Video accessed 24 de mayo de 2024. https://youtu.be/eiZiHNeJn7g
Read Next
MÁS INFORMACIÓN
